Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using spinal cord stimulation to improve upper limb rehabilitation

Official title: Upper Limb Spinal Cord Stimulation for Rehabilitation Enhancement

Run by University College, London · NCT05991804 · Data updated 2026-11-12

This study is testing if adding a gentle spinal cord stimulation treatment to regular rehab can help people with recent spinal cord injuries improve their arm function and reduce stiffness.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment18 (estimated)
SponsorUniversity College, London
Academic / other
Locations1 site (London)
StatusRecruiting
StartedJune 28, 2023
Main results expectedApril 16, 2028
Study endsApril 16, 2028
Registry record updatedDecember 10, 2025
Trial IDNCT05991804 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with recent spinal cord injuries at levels C1-C8 who are currently inpatient at the Royal National Orthopaedic Hospital.

Probably not a fit

Patients with certain conditions such as pregnancy, cardiac pacemakers, or other musculoskeletal diagnoses affecting the upper limbs may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of adding non-invasive transcutaneous spinal cord stimulation (TSCS) to standard inpatient rehabilitation for individuals with acute spinal cord injuries affecting the upper limbs. Participants will be randomly assigned to either receive standard rehabilitation alone or have TSCS incorporated into their treatment. The aim is to assess improvements in upper limb function and spasticity, which are critical for daily living activities. Regular assessments and follow-up interviews will be conducted to evaluate the participants' experiences and outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly enhance upper limb function and quality of life for patients with spinal cord injuries.

How similar studies have gone: While the use of spinal cord stimulation is gaining interest, this specific application of TSCS for upper limb rehabilitation in acute spinal cord injury is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Over the age of 18
2. Recent spinal cord injury (inpatient at the RNOH)
3. Spinal cord injury level C1-C8
4. AIS A-D
5. Willing and able to provide informed consent

Exclusion Criteria:

1. Women who are pregnant, planning pregnancy or breastfeeding
2. Those who have a cardiac pacemaker
3. Active device at stimulating electrode site
4. Any other musculoskeletal diagnosis affecting the upper limbs
5. Spinal malignancy
6. Spinal cord injury due to cancerous growth
7. Auto-immune disorder
8. Ongoing infection
9. Uncontrolled autonomic dysreflexia
10. Complex regional pain syndrome
11. Neurological degenerative diseases
12. Peripheral nerve damage affecting the upper limbs
13. Taking part in a conflicting research study
14. People who are unable to tolerate TSCS during their first session

Where it's running

  • Royal National Orthopaedic Hospital
    London, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: Lynsey Duffell, PhD — University College, London
  • Study coordinator: Joseph Steel, BSc
  • Email: joseph.steel@nhs.net
  • Phone: 02089095500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.